| Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis. | Circular RNA SMARCA5 inhibits cholangiocarcinoma via microRNA-95-3p/tumor necrosis factor receptor associated factor 3 axis.
Wang G, Gao X, Sun Z, He T, Huang C, Li S, Long H., Free PMC Article | 09/14/2023 |
| LINC01116 Regulates the Proliferation and Apoptosis of Nucleus Pulposus Cells through miR-9-5p-mediated ZIC5 and the Wnt Pathway and Affects the Progression of Intervertebral Disc Degeneration. | LINC01116 Regulates the Proliferation and Apoptosis of Nucleus Pulposus Cells through miR-9-5p-mediated ZIC5 and the Wnt Pathway and Affects the Progression of Intervertebral Disc Degeneration.
Xu S, Li Y, Zhang J, Li Z. | 06/5/2023 |
| Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis. | Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis.
Chen Z, Gong X, Cheng C, Fu Y, Wu W, Luo Z. | 02/11/2023 |
| Differential Expression of Urinary Exosomal miRNA in Idiopathic Membranous Nephropathy and Evaluation of its Diagnostic Value. | Differential Expression of Urinary Exosomal miRNA in Idiopathic Membranous Nephropathy and Evaluation of its Diagnostic Value.
Guo S, Hao H, Li S, Zhang L, Li R. | 05/7/2022 |
| Analysis of the diagnostic and prognostic value of miR-9-5p in carotid artery stenosis. | Analysis of the diagnostic and prognostic value of miR-9-5p in carotid artery stenosis.
Liu H, Zhou J, Jiang W, Wang F., Free PMC Article | 01/29/2022 |
| MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling. | MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling.
Ni Q, Zhang Y, Tao R, Li X, Zhu J., Free PMC Article | 07/24/2021 |
| MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF. | MicroRNA-95-3p inhibits cell proliferation and metastasis in colorectal carcinoma by HDGF.
Hong YG, Huang ZP, Liu QZ, E JF, Gao XH, Xin C, Zhang W, Li P, Hao LQ., Free PMC Article | 07/3/2021 |
| Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer. | Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer.
Guan H, Peng R, Fang F, Mao L, Chen Z, Yang S, Dai C, Wu H, Wang C, Feng N, Xu B, Chen M. | 04/13/2021 |
| miR95 promotes osteosarcoma growth by targeting SCNN1A. | miR‑95 promotes osteosarcoma growth by targeting SCNN1A.
Geng Y, Zhao S, Jia Y, Xia G, Li H, Fang Z, Zhang Q, Tian R., Free PMC Article | 02/6/2021 |
| [Effects of microRNA95 targeting FOXD1 gene on radiosensitivity of colorectal cancer loVo cells and its mechanism]. | [Effects of microRNA95 targeting FOXD1 gene on radiosensitivity of colorectal cancer loVo cells and its mechanism].
Liang WL, Xiao TB, Yuan F, Cao YB, Yan DG. | 11/21/2020 |
| miR-95 was downregulated in gastric cancer and adjacent normal tissue samples, as well as gastric cancer cell lines. Expression of miR-95 was associated with tumor size, TNM stage and lymph node metastasis. Overexpression of miR-95 significantly suppressed cell proliferation, migration and invasion. Moreover, miR-95 inhibited epithelial-to-mesenchymal transition by directly binding the 3'-UTR of Slug. | Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.
Zhang W, Sun J, Chen J, Xu C, Zhang L. | 09/12/2020 |
| MiR-95-3p promoted the development of prostatic cancer via targeting DKK3 and activating the Wnt/beta-catenin pathway | MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
Xi M, Cheng L, Hua W, Zhou YL, Gao QL, Yang JX, Qi SY. | 07/18/2020 |
| that miR-95-3p might act as a potential tumor suppressor in osteosarcoma by targeting hepatoma-derived growth factor | Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
Liu X, Ma W, Ma J, Xiao L, Hao D. | 01/18/2020 |
| AC-miR-95-5p-Exos may act as an HDAC2/8 inhibitor and exhibit potential as a disease-modifying osteoarthritis drug. | Exosomal miR-95-5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8.
Mao G, Hu S, Zhang Z, Wu P, Zhao X, Lin R, Liao W, Kang Y., Free PMC Article | 12/7/2019 |
| Study have found that the serum expression of microRNA-95-3p was upregulated in patients with osteosarcoma. Downregulation of microRNA-95-3p expression suppresses cell growth, induced apoptosis, increased caspase-3 and caspase-9 activities and Bax/Bcl-2 protein expression in osteosarcoma cell through TGF-beta/CDKN1A/ p21/cyclin D1 expression. | Downregulation of microRNA-95-3p suppresses cell growth of osteosarcoma via CDKN1A/p21 expression.
Zhao X, Yang Y, Xu J, Luo Y, Xin Y, Wang Y. | 07/21/2018 |
| These results demonstrate that miR-95-3p is a potential new marker for Hepatocellular carcinoma and regulates hepatocarcinogenesis by directly targeting CDKN1A/p21 expression. | Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J, Yao Y, Song Q, Li S, Hu Z, Yu Y, Hu C, Da X, Li H, Chen Q, Wang QK., Free PMC Article | 06/16/2018 |
| Data confirm that a combination of serum expression levels of microRNA-95 and microRNA-190 is an accurate and non-invasive tool for differential diagnosis of thyroid nodules in an Italian population. | Diagnostic Value of Circulating microRNA-95 and -190 in the Differential Diagnosis of Thyroid Nodules: A Validation Study in 1000 Consecutive Patients.
Pilli T, Cantara S, Marzocchi C, Cardinale S, Santini C, Cevenini G, Pacini F. | 05/5/2018 |
| Knockdown of miRNA-95 expression increased the radiosensitivity of non-small cell lung cancer (NSCLC), promoted tumor cell apoptosis and decreased cellular proliferation. In vivo assays demonstrated reduced tumor growth and resistance to radiation in tumor xenografts by downregulating miRNA-95. Study demonstrated a potential therapeutic measure of miRNA-95 as a radiosensitive marker for the treatment of NSCLC. | Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer.
Ma W, Ma CN, Li XD, Zhang YJ. | 12/24/2016 |
| Authors found that miR-95-3p suppressed orthotopic tumorigenicity and brain metastasis in vivo and increased overall survival and brain metastasis-free survival. | Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1.
Hwang SJ, Lee HW, Kim HR, Song HJ, Lee DH, Lee H, Shin CH, Joung JG, Kim DH, Joo KM, Kim HH., Free PMC Article | 07/16/2016 |
| Data show miR95 expression level positively related to glioma grade and its downregulation affects proliferation, invasion and apoptosis by targeting CELF2. MiR95 is identified as a putative therapeutic target and CELF2 as a potential tumor suppressor. | Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B, Jiao BH, Fan FS, Lu SK, Song J, Guo CY, Yang JK, Yang L. | 05/21/2016 |
| miR-95 functions as an oncogene role in non-small cell lung cancer cells by directly targeting SNX1. | MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
Chen X, Chen S, Hang W, Huang H, Ma H. | 04/23/2016 |
| hsa-miR-665 and hsa-miR-95 were downregulated in GSRCC but upregulated in intestinal gastric adenocarcinoma, and the relatively differential expression of the miRNAs negatively controlling their target genes, GLI2 and PLCG1 | Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction.
Chen J, Sun D, Chu H, Gong Z, Zhang C, Gong B, Li Y, Li N, Jiang L. | 02/6/2016 |
| miR-95 depletes SUMF1 protein levels and suppresses sulfatase activity, causing the disruption of proteoglycan catabolism and lysosomal function. | A non-conserved miRNA regulates lysosomal function and impacts on a human lysosomal storage disorder.
Frankel LB, Di Malta C, Wen J, Eskelinen EL, Ballabio A, Lund AH. | 11/21/2015 |
| Targeting inhibition of miR-21 and miR-95 can inhibit tumor growth through elevating PTEN, SNX1, and SGPP1 expression and inhibiting Akt phosphorylation. | Abnormal Expression of miR-21 and miR-95 in Cancer Stem-Like Cells is Associated with Radioresistance of Lung Cancer.
Zhang J, Zhang C, Hu L, He Y, Shi Z, Tang S, Chen Y. | 08/1/2015 |
| We have identified for the first time two miRNAs, mir-95 and mir-190, differently expressed in serum of papillary thyroid cancer patients who in combination allow the differential diagnosis of thyroid nodules with great accuracy in our study population | Circulating miRNA95 and miRNA190 are sensitive markers for the differential diagnosis of thyroid nodules in a Caucasian population.
Cantara S, Pilli T, Sebastiani G, Cevenini G, Busonero G, Cardinale S, Dotta F, Pacini F. | 01/17/2015 |